L. Ayash

发表

Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents

Paramveer Singh, A. Deol, Seongho Kim, 2021, Leukemia & lymphoma.

Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohort

A. Deol, E. Waller, L. Lum, 2015, Bone Marrow Transplantation.

Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP cells.

B. Teicher, T. Herman, L. Ayash, 1991, Cancer letters.

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

B. Teicher, J. Eder, A. Elias, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long term follow‐up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide

J. Abrams, G. Bentley, V. Ratanatharathorn, 2010, American journal of hematology.

Outcomes of Fludarabine, Melphalan and Total Body Irradiation as a Reduced Intensity Conditioning Regimen in Matched Donor Allogeneic Peripheral Blood Stem Cell Transplantation: Outcomes of Flu-Mel-TBI.

A. Deol, Seongho Kim, V. Ratanatharathorn, 2021, Transplantation and cellular therapy.

Pre-transplant hypomethylating agents do not influence post-transplant survival in myelodysplastic syndrome

A. Deol, Seongho Kim, V. Ratanatharathorn, 2019, Leukemia & lymphoma.

Absolute lymphocyte count on the first day of thymoglobulin predicts relapse-free survival in matched unrelated peripheral blood stem cell transplantation

A. Deol, Seongho Kim, V. Ratanatharathorn, 2020, Leukemia & lymphoma.

High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Ovarian Cancer: An Autologous Blood and Marrow Transplant Registry Report

J. Klein, T. Shea, J. Veum-Stone, 2000, Annals of Internal Medicine.

Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma

J. Abrams, A. Deol, J. Zonder, 2012, Journal of chemotherapy.

A Phase I Study of Bortezomib During Maintenance Phase After High-Dose Melphalan and Autologous Stem Cell Transplantation In Patients with Multiple Myeloma

J. Abrams, A. Deol, L. Lum, 2010 .

Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.

B. Teicher, A. Elias, L. Schnipper, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Impact of pre-transplant induction therapy on outcomes of patients who undergo autologous stem cell transplantation for mantle cell lymphoma in first complete remission.

A. Deol, Seongho Kim, V. Ratanatharathorn, 2021, Hematology/oncology and stem cell therapy.

High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.

Shaun Parsons, E. Guinan, P. Mauch, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.

A. Elias, R. Gonin, C. Wheeler, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose thiotepa alone and in combination regimens with bone marrow support.

C. Begg, B. Teicher, T. Shea, 1990, Seminars in oncology.

The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.

A. Elias, L. Schnipper, K. Antman, 1993, Journal of hematotherapy.

Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma.

A. Deol, Seongho Kim, V. Ratanatharathorn, 2019, Leukemia research.

Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte‐colony‐stimulating factor: implications for yield of hematopoietic progenitor cell collections

G. Demetri, C. Wheeler, L. Ayash, 1996, Transfusion.

Analysis of 4-hydroxycyclophosphamide in human blood.

E. Frei, A. Rosowsky, L. Ayash, 1995, Analytical biochemistry.

A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients

T. Shea, J. Eder, A. Elias, 2004, Cancer Chemotherapy and Pharmacology.

Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma

J. Abrams, A. Deol, J. Zonder, 2013, Supportive Care in Cancer.

Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trial

J. Abrams, L. Lum, V. Ratanatharathorn, 2012, Supportive Care in Cancer.

West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation

J. Ferrara, V. Ratanatharathorn, P. Reddy, 2004, Bone Marrow Transplantation.

Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.

P. Richardson, B. Teicher, L. Schnipper, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.

T. Braun, M. Becker, G. Yanik, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high‐dose chemotherapy support

J. Axelrod, L. Shulman, R. Benjamin, 1995, Transfusion.

GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols

A. Elias, L. Schnipper, K. Antman, 1991, Breast Cancer Research and Treatment.

Dose-intensive therapy for limited-stage small-cell lung cancer: long-term outcome.

P. Richardson, A. Elias, L. Schnipper, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.

A. Elias, R. Gonin, L. Schnipper, 1995, Bone marrow transplantation.

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.

J. Eder, A. Elias, L. Schnipper, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive combined modality therapy for limited-stage small-cell lung cancer.

J. Eder, A. Elias, C. Wheeler, 1993, Journal of the National Cancer Institute.

Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients

A. Deol, Seongho Kim, L. Lum, 2017, Supportive Care in Cancer.

T. Braun, V. Ratanatharathorn, J. Uberti, 2007, American journal of hematology.

Long-term follow up of patients proceeding to transplant using plerixafor mobilized stem cells and incidence of secondary myelodysplastic syndrome/AML

J. Abrams, A. Deol, L. Lum, 2013, Bone Marrow Transplantation.

High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancer.

A. Elias, L. Schnipper, K. Antman, 1993, Chest.

A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.

J. Abrams, A. Deol, J. Zonder, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation

P. Hari, N. Ueno, R. Gale, 2017, Journal of Cancer.

Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.

T. Greenough, L. Nadler, J. Eder, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of High-Dose Adjuvant Chemotherapy Followed by Autologous Stem Cell Transplantation in Locally Advanced Triple-Negative Breast Cancer: A Retrospective Chart Review

J. Abrams, A. Deol, V. Ratanatharathorn, 2022, Journal of oncology.

Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes

T. Braun, V. Ratanatharathorn, C. Reynolds, 2004, Bone Marrow Transplantation.

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.

M. Becker, J. Ferrara, V. Ratanatharathorn, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Anti-CD20 Chimeric Monoclonal Antibody Treatment of Refractory Immune-Mediated Thrombocytopenia in a Patient with Chronic Graft-versus-Host Disease

G. Yanik, J. Ferrara, V. Ratanatharathorn, 2000, Annals of Internal Medicine.

Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation

G. Demetri, A. Elias, K. Antman, 1994, British journal of haematology.

A preclinical model for sequential high-dose chemotherapy

B. Teicher, E. Frei, S. Holden, 2004, Cancer Chemotherapy and Pharmacology.

High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity

A. Elias, K. Antman, C. Wheeler, 2004, Cancer Chemotherapy and Pharmacology.

Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide±hepatic enzyme effectors

B. Teicher, Joel E. Wright, S. Holden, 1996, Cancer Chemotherapy and Pharmacology.

Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation

A. Deol, Seongho Kim, S. Revankar, 2018, Bone Marrow Transplantation.

Targeting CD138-/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity.

A. Thakur, A. Deol, J. Zonder, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Liver Graft‐Versus‐Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients

A. Deol, V. Ratanatharathorn, J. Uberti, 2019, American journal of hematology.

High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer

L. Ayash, 1994, Cancer.

High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients.

A. Deol, E. Waller, L. Lum, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.

S. Forman, A. Deol, L. Lum, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.

A. Rosowsky, J. Eder, A. Elias, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.

A. Deol, L. Lum, V. Ratanatharathorn, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens.

J. Eder, A. Elias, M. Seiden, 1992, Bone marrow transplantation.

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.

D. Fairclough, A. Elias, L. Schnipper, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.

G. Demetri, A. Elias, C. Wheeler, 1992, Blood.

Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.

T. Braun, G. Yanik, R. Hutchinson, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

14 A phase I/II study of recombinant human keratinocyte growth factor (KGF) in patients with high risk hematologic malignancies undergoing mismatched related or unrelated donor transplant

T. Braun, M. Becker, G. Yanik, 2003 .

Grade 3–4 cytokine release syndrome is associated with poor survival in haploidentical peripheral blood stem cell transplantation

A. Deol, Seongho Kim, V. Ratanatharathorn, 2021, Leukemia & lymphoma.

Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

T. Braun, V. Ratanatharathorn, P. Reddy, 2006, Bone Marrow Transplantation.

Post-transplant Cyclophosphamide versus Thymoglobulin in HLA-Mismatched Unrelated Donor Transplant for AML and MDS.

A. Deol, Seongho Kim, V. Ratanatharathorn, 2021, Transplantation and cellular therapy.

Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G‐CSF or G‐CSF and plerixafor mobilized grafts

Paramveer Singh, A. Deol, Seongho Kim, 2020, American journal of hematology.

BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.

A. Deol, Seongho Kim, L. Lum, 2015, Clinical lymphoma, myeloma & leukemia.

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer

G. Demetri, P. Richardson, R. Joyce, 2001, Bone Marrow Transplantation.

Effect of aprepitant on intravenous tacrolimus disposition in reduced intensity hematopoietic stem cell transplantation

P. Jacobson, D. Edwards, M. Abidi, 2008, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis

A. Deol, Seongho Kim, V. Ratanatharathorn, 2021, Annals of Hematology.

Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.

M. Strawderman, J. Eder, A. Elias, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma

T. Braun, L. Dawson, A. Eisbruch, 2001, Bone Marrow Transplantation.

Lenalidomide maintenance after second autologous stem cell transplant improves overall survival in multiple myeloma

A. Deol, Seongho Kim, V. Ratanatharathorn, 2020, Leukemia and Lymphoma.

G-CSF use post peripheral blood stem cell transplant is associated with faster neutrophil engraftment, shorter hospital stay and increased incidence of chronic GVHD

A. Deol, Seongho Kim, V. Ratanatharathorn, 2020, Leukemia & lymphoma.

CD20-targeted T cells after stem cell transplantation for high risk and refractory non-Hodgkin's lymphoma.

A. Thakur, A. Deol, Qin Liu, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.

L. Dawson, M. Schipper, A. Eisbruch, 2004, International journal of radiation oncology, biology, physics.

R-BEAM versus Reduced Intensity Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Relapsed Refractory Diffuse Large B Cell Lymphoma.

A. Deol, Seongho Kim, V. Ratanatharathorn, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation

A. Deol, Seongho Kim, V. Ratanatharathorn, 2020, Bone Marrow Transplantation.

Encouraging Outcomes in African-American Patients with Use of Post-Transplant Cyclophosphamide after HLA Mismatched Hematopoietic Stem Cell Transplant

A. Deol, L. Lum, D. Aggen, 2015 .

Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant

A. Deol, L. Lum, V. Ratanatharathorn, 2014, Journal of clinical apheresis.

Lower intensity of preparative regimen for allogeneic stem cell transplantation from related donor in patients with advanced hematologic malignancy is associated with poor outcome

G. Yanik, R. Hutchinson, J. Ferrara, 2000 .

High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma.

C. Shapiro, P. Richardson, A. Elias, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.

A. Elias, L. Schnipper, K. Antman, 1994, Seminars in Oncology.

Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation

A. Deol, Seongho Kim, L. Lum, 2016, American journal of hematology.

Induction Of Anti-Myeloma Cellular and Humoral Immunity By Pre-Targeting Clonogenic Myeloma Cells Prior To Stem Cell Transplant With T Cells Armed With Anti-CD3 x Anti-CD20 Bispecific Antibody Leads To Transfer Of Cellular and Humoral Anti-Myeloma Immunity

A. Thakur, A. Deol, J. Zonder, 2013 .

Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.

C. Shapiro, G. Demetri, R. Gelman, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?

Nadine H Abdallah, A. Deol, Seongho Kim, 2018, Bone Marrow Transplantation.

A phase II study of tacrolimus and thymoglobulin as graft‐versus‐host‐disease prophylaxis in related donor allogeneic hematopoietic cell transplantation

A. Deol, V. Ratanatharathorn, J. Uberti, 2018, American journal of hematology.

Allogeneic stem cell transplant outcomes between TBI-containing reduced intensity and myeloablative conditioning regimens for ALL in complete remission

A. Deol, Seongho Kim, V. Ratanatharathorn, 2023, Leukemia & lymphoma.

Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study

A. Elias, L. Schnipper, K. Antman, 2005, Journal of Cancer Research and Clinical Oncology.

Chronic graft-versus-host disease: clinical manifestation and therapy

H. Lazarus, J. Uberti, V. Ratanatharathorn, 2001, Bone Marrow Transplantation.

A Retrospective Comparison of Outcomes in AML/MDS Patients Undergoing Allogeneic Stem Cell Transplant with Reduced Intensity and Myeloablative Conditioning Regimens

A. Deol, Seongho Kim, V. Ratanatharathorn, 2017 .

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.

M. Becker, J. Ferrara, V. Ratanatharathorn, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation

A. Deol, Seongho Kim, S. Revankar, 2018, Bone Marrow Transplantation.

Impact of pre-transplant induction therapy on outcomes of patients who undergo autologous stem cell transplantation for mantle cell lymphoma in first complete remission.

A. Deol, Seongho Kim, V. Ratanatharathorn, 2020, Hematology/oncology and stem cell therapy.

T. Braun, V. Ratanatharathorn, J. Uberti, 2007, American journal of hematology/oncology.

J. Abrams, A. Deol, J. Zonder, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.

A. Deol, Seongho Kim, L. Lum, 2015, Clinical lymphoma, myeloma & leukemia.

Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT

A. Deol, L. Lum, V. Ratanatharathorn, 2015, Bone Marrow Transplantation.

The use of defibrotide in BMT-associated veno-occlusive disease

A. Krishnan, P. Richardson, D. Kufe, 1995 .

Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review

T. Braun, J. Ferrara, E. R. Broun, 2001, Bone Marrow Transplantation.

Haploidentical vs. mismatched unrelated donor transplants with posttransplant cyclophosphamide-based GVHD prophylaxis.

A. Deol, Seongho Kim, V. Ratanatharathorn, 2024, Bone marrow transplantation.